Commitments and Contingencies (Details)	1 Months Ended			2 Months Ended	9 Months Ended	10 Months Ended
	Jul. 31, 2020 USD ($)	Jan. 31, 2020 USD ($)	Sep. 30, 2014 USD ($) shares	Dec. 31, 2020 USD ($) $ / ft²	Sep. 30, 2021 USD ($) m²	Oct. 31, 2020 USD ($) $ / ft²	Mar. 31, 2020 $ / shares shares
Other Commitments [Line Items]
Commitments related to agreements					$ 425,000
Maximum payment for commitment milestones					$ 7,900,000
Percentage for royalties					6.00%
Office space (in Square Meters) | m²					6,200
Rent expenses per month				$ 11,108		$ 11,883
Rent expenses per square foot | $ / ft²				21.50		23.00
Cash paid to acquire Hy Biopharma intangible asset			$ 275,000
Issuance of shares for assets (in shares) | shares			184,912
Fair value of shares issued in connection with Hy BioPharma asset purchase			$ 3.75
Shares exercisable (in shares) | shares							1,956,182
Effective price per share (in Dollars per share) | $ / shares							$ 2.56
Additional Payments					$ 5,000,000.0
Ownership of company outstanding					19.90%
Emergent BioSolutions
Other Commitments [Line Items]
Amount of damages to be recovered	$ 19,000,000
Invoices	$ 331,000
Minimum
Other Commitments [Line Items]
Authorized shares to be issued		$ 5,000
Maximum
Other Commitments [Line Items]
Authorized shares to be issued		$ 500,000